IRD

Opus Genetics is a biotechnology company focused on developing genetic medicines for inherited retinal diseases and other genetic disorders. The company utilizes its proprietary gene therapy platforms to create treatments targeting the underlying genetic causes of vision loss and blindness. Opus Genetics is advancing a pipeline of product candidates designed to restore or preserve vision in patients with rare inherited eye diseases. The company combines cutting-edge genetic engineering with clinical development expertise to bring transformative therapies to patients with limited treatment options.